Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronjon Chakraverty

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Blood|January 29, 2026
Menin inhibitors: a 2-in-1 defense versus AML immune evasionRonjon Chakraverty
Blood|April 9, 2026
GVHD fails the acid testRonjon Chakraverty
Haematologica|November 6, 2012
Do educated natural killer cells make the grade in treating acute myeloid leukemia?Ronjon Chakraverty
The Journal of Clinical Investigation|January 28, 2014
An unexpected role for platelets in blocking Th17 differentiationRonjon Chakraverty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2024
How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?Ronjon Chakraverty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Allogeneic transplantation for lymphomaRonjon Chakraverty, Stephen Mackinnon
Blood|March 1, 2007
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemiaRonjon Chakraverty, Megan Sykes
The Journal of Clinical Investigation|April 1, 2024
The road to refractory graft-versus-host disease is paved with good intentionsDaniel North, Ronjon Chakraverty
Blood|August 9, 2021
Graft-versus-host disease: a disorder of tissue regeneration and repairRonjon Chakraverty, Takanori Teshima
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Blood|January 29, 2026
Menin inhibitors: a 2-in-1 defense versus AML immune evasionRonjon Chakraverty
Blood|April 9, 2026
GVHD fails the acid testRonjon Chakraverty
Haematologica|November 6, 2012
Do educated natural killer cells make the grade in treating acute myeloid leukemia?Ronjon Chakraverty
The Journal of Clinical Investigation|January 28, 2014
An unexpected role for platelets in blocking Th17 differentiationRonjon Chakraverty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2024
How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?Ronjon Chakraverty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Allogeneic transplantation for lymphomaRonjon Chakraverty, Stephen Mackinnon
Blood|March 1, 2007
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemiaRonjon Chakraverty, Megan Sykes
The Journal of Clinical Investigation|April 1, 2024
The road to refractory graft-versus-host disease is paved with good intentionsDaniel North, Ronjon Chakraverty
Blood|August 9, 2021
Graft-versus-host disease: a disorder of tissue regeneration and repairRonjon Chakraverty, Takanori Teshima
Blood|January 22, 2011
Families get mobilized to treat AMLStephen Mackinnon, Ronjon Chakraverty
Pageof 8